BioSpace News Archive

Press Releases

Yaqrit’s HE candidates set for phase 3 as company shows underpinning data at EASL

May 7, 2025
·
4 min read
Press Releases

Final Data From the Phase 3 MYR301 Study Demonstrated Longer Treatment With Bulevirtide Was Associated With Sustaining Undetectability After Stopping Treatment

May 7, 2025
·
7 min read
Press Releases

ENHERTU® Followed by THP Before Surgery Showed Statistically Significant and Clinically Meaningful Improvement in Pathologic Complete Response in Patients With High-Risk HER2 Positive Early-Stage Breast Cancer in DESTINY-Breast11 Phase 3 Trial

May 7, 2025
·
19 min read
Press Releases

European Commission approves TREMFYA® (guselkumab), the first dual-acting IL-23 inhibitor offering both subcutaneous and intravenous induction options, for adult patients with moderately to severely active Crohn’s disease

May 7, 2025
·
18 min read
Press Releases

Oculis to Present at Upcoming May 2025 Investor Conferences

May 7, 2025
·
2 min read
Press Releases

Isarna Therapeutics Presents Positive Phase 2 BETTER Trial Final Results at ARVO 2025

May 7, 2025
·
2 min read
Press Releases

Bulletin from the Annual General Meeting in Alligator Bioscience AB on 7 May 2025

May 7, 2025
·
4 min read
Press Releases

AACR 2025: Brenus Pharma Presents Late-breaking Preclinical Data on its “off-the-shelf” Next-generation Vaccine-based Immunotherapy Candidate, STC-1010, Now Moving to Clinic

May 7, 2025
·
2 min read
Press Releases

LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy

May 7, 2025
·
6 min read
Press Releases

LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance

May 7, 2025
·
19 min read